80 related articles for article (PubMed ID: 3742433)
1. Regulation of pulsatile secretion of progesterone during the human luteal phase.
Steele PA; Braund W; Judd SJ
Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
[TBL] [Abstract][Full Text] [Related]
2. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
Braund W; Roeger DC; Judd SJ
J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
[TBL] [Abstract][Full Text] [Related]
3. [Pulsatile secretion of prolactin during the human menstrual cycle].
Masaoka K; Kitazawa M; Niibe T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1793-9. PubMed ID: 3209907
[TBL] [Abstract][Full Text] [Related]
4. The source of pulsatile secretion of progesterone during the human follicular phase.
Judd S; Terry A; Petrucco M; White G
J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
[TBL] [Abstract][Full Text] [Related]
5. The corpus luteum: determinants of progesterone secretion in the normal menstrual cycle.
Soules MR; Clifton DK; Steiner RA; Cohen NL; Bremner WJ
Obstet Gynecol; 1988 May; 71(5):659-66. PubMed ID: 3357651
[TBL] [Abstract][Full Text] [Related]
6. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.
Filicori M; Butler JP; Crowley WF
J Clin Invest; 1984 Jun; 73(6):1638-47. PubMed ID: 6427277
[TBL] [Abstract][Full Text] [Related]
9. Different effects of subnormal levels of progesterone on the pulsatile and surge mode secretion of luteinizing hormone in ovariectomized goats.
Kim S; Tanaka T; Kamomae H
Biol Reprod; 2003 Jul; 69(1):141-5. PubMed ID: 12606364
[TBL] [Abstract][Full Text] [Related]
10. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
11. Sustained effects of opioid antagonism during the normal human luteal phase.
Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
[TBL] [Abstract][Full Text] [Related]
12. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
Khoury SA; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
[TBL] [Abstract][Full Text] [Related]
13. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
Van Vugt DA; Lam NY; Ferin M
Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
[TBL] [Abstract][Full Text] [Related]
14. Ovariectomy during the luteal phase influences secretion of prolactin, growth hormone, and insulin-like growth factor-I in the bitch.
Lee WM; Kooistra HS; Mol JA; Dieleman SJ; Schaefers-Okkens AC
Theriogenology; 2006 Jul; 66(2):484-90. PubMed ID: 16442609
[TBL] [Abstract][Full Text] [Related]
15. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.
Suganuma C; Kuroiwa T; Tanaka T; Kamomae H
Anim Reprod Sci; 2007 Oct; 101(3-4):285-94. PubMed ID: 17027203
[TBL] [Abstract][Full Text] [Related]
16. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
[TBL] [Abstract][Full Text] [Related]
17. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
19. The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women.
Maruncic M; Casper RF
J Clin Endocrinol Metab; 1987 Jan; 64(1):148-52. PubMed ID: 3782428
[TBL] [Abstract][Full Text] [Related]
20. The effects of prolonged, intracerebroventricular prolactin treatment on luteinizing hormone secretion, catecholaminergic activity and estrous behavior in ewes.
Misztal T; Romanowicz K; Tomaszewska-Zaremba D; Wójcik-Gładysz A; Barcikowski B
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):215-21. PubMed ID: 15127327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
